Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER

CEFOXITIN SODIUM

Standard Dose
EQ 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 050581 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFOXITIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MERCK Submission history Latest submission status date: 1997-02-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview MEFOXIN IN DEXTROSE 5% IN PLASTIC CONTAINER is listed in Drugs@FDA under application 050581 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFOXITIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MERCK Submission history Latest submission status date: 1997-02-27 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Discontinued
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.